DBVT

DBVT

USD

DBV Technologies S.A. American Depositary Shares

$8.720-0.250 (-2.787%)

Echtzeitkurs

Healthcare
Biotechnologie
Frankreich

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$8.970

Hoch

$9.046

Tief

$8.720

Volumen

0.01M

Unternehmensfundamentaldaten

Marktkapitalisierung

252.2M

Branche

Biotechnologie

Land

France

Handelsstatistiken

Durchschnittliches Volumen

0.44M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $0.441Aktuell $8.720Hoch $12.78

Ähnliche Nachrichten

GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI Congress 2025

Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company, today announced upcoming participation in the

Mehr anzeigen
DBV Technologies to Participate in Upcoming EAACI Congress 2025
GlobeNewswire

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (TRQX:DBVp), a clinical-stage

Mehr anzeigen
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
GlobeNewswire

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025

Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025 (Article 223-16 of the General Regulations of

Mehr anzeigen
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
GlobeNewswire

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company (the

Mehr anzeigen
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Analyst Upgrades

JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21

JMP Securities analyst Jonathan Wolleben maintains DBV Technologies with a Market Outperform and raises the price target from $15 to $21.

Mehr anzeigen
JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $21